Mechanical Thrombolysis in Acute Ischemic Stroke With Endovascular Photoacoustic Recanalization
Stroke 35:1112-1116, Berlis,A.,et al, 2004
US Nat'l Survey of Phy Pract for 2nd & Tertiary Prevent of Ischemic Stroke, Med Therapy in Carotid Art Stenosis
Stroke 27:1473-1478, Goldstein,L.B.,et al, 1996
Use of Intravenous Heparin by North American Neurologists
Stroke 33:1574-1577, Al-Sadat,A.,et al, 2002
Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001
Acute Stroke Management in the Local General Hospital
Stroke 32:866-870, Handschu,R.,et al, 2001
Changing Practice and Costs of Carotid Endarterectomy in Toronto,Canada
Stroke 29:2014-2017, Smurawska,L.T.,et al, 1998
Clinical Characteristics & Mgt of Acute Stroke in Pts with Atrial Fib Admitted to US Univ Hosp
Neurol 48:1598-1604, Albers,G.W.,et al, 1997
Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996
US National Survey of Physician Practices for the Secondary & Tertiary Prevention of Ischemic Stroke:Common Practices
Stroke 26:1607-1615, Goldstein,L.B.,et al, 1995
A Follow-up Survey of Clinical Practices for the Use of Heparin, Warafarin, & Aspirin
Neurol 44:618-621, Alberts,M.J.,et al, 1994
How Twin Cities Neurologists Treat Ischemic Stroke, Policies and Trends
Arch Neurol 50:1098-1103, Anderson,D.C., 1993
Use of Antithrombotic Drugs in the Treatment of Acute Ischemic Stroke:A Survey of Neurologist in Practice in the US
Neurol 39:1631-1634, Marsh,E.E.,et al, 1989
The COVID-19 Pandemic and the Ethical Duties of the Neurologist
Neurol 95:167-172, Rubin, M.A.,et al, 2020